Krishnan Suma 的 Form 4 申報
Krystal Biotech, Inc.（KRYS），2023/1/3 申報
- 申報編號
- 0001298711-23-000002
- 申報時間
- 2023/1/3
- 交易日
- 2022/12/29-2023/1/3
- 申報延遲
- 5 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $156.0 萬。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Krishnan SumaCIK 0001298711 | 董事、高階主管（President, R&D）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/29 | Common Stock | S賣出處分 | −7,484 | $80.30F2 | −$600,965.2 | 1,708,429 | 直接 | 重複申報 |
| 2022/12/29 | Common Stock | S賣出處分 | −528 | $81.10F3 | −$42,820.8 | 1,707,901 | 直接 | 重複申報 |
| 2022/12/29 | Common Stock | S賣出處分 | −7,447 | $80.28F6 | −$597,845.16 | 1,769,699 | 間接 | 重複申報 |
| 2022/12/29 | Common Stock | S賣出處分 | −563 | $81.11F8 | −$45,664.93 | 1,769,136 | 間接 | 重複申報 |
| 2023/1/3 | Common Stock | S賣出處分 | −1,700 | $80.33F9 | −$136,561 | 1,706,201 | 直接 | 重複申報 |
| 2023/1/3 | Common Stock | S賣出處分 | −1,700 | $80.33F10 | −$136,561 | 1,767,436 | 間接 | 重複申報 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The transaction was executed in multiple trades ranging from $80.0000 to $80.9100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The transaction was executed in multiple trades ranging from $81.0000 to $81.2000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The transaction was executed in multiple trades ranging from $80.0000 to $80.9900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The transaction was executed in multiple trades ranging from $81.0000 to $81.2700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F9
The transaction was executed in multiple trades ranging from $80.0000 to $80.6700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F10
The transaction was executed in multiple trades ranging from $80.0000 to $80.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。